HNGE Earnings & Financial Statements
Hinge Health, Inc.
$98.35
+$0.68(+0.70%)
47
Overall
20
Value
63
Tech
60
Quality
Market Cap
$7.94B
Volume
2.48M
52W Range
$30.08 - $99.73
Target Price
$108.59
HNGE earnings and financial statements: Hinge Health, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
HNGE Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $587.86M | $390.40M | $292.73M |
| Cost of revenue | $119.64M | $90.50M | $98.55M |
| Operating income | -$546.37M | -$31.91M | -$130.51M |
| EBITDA | -$475.46M | $24.61M | -$82.58M |
| Net income | -$528.26M | -$11.93M | -$108.95M |
| EPS (diluted) | $-7.77 | $-0.88 | $-8.31 |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total assets | $744.76M | $673.26M | $622.53M |
| Total liabilities | $366.23M | $256.56M | $195.25M |
| Shareholders’ equity | $178.66M | $416.70M | $427.28M |
| Cash and equivalents | $208.00M | $300.79M | $234.95M |
| Long-term debt | $3.82M | $7.26M | $11.10M |
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating cash flow | $171.44M | $49.00M | -$63.91M |
| Capital expenditure | -$6.06M | - | - |
| Free cash flow | $165.38M | $47.96M | -$65.89M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HNGE | $98.35 | +0.7% | 2.48M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |